申请人:Hartmann Rolf
公开号:US20090105278A1
公开(公告)日:2009-04-23
The invention relates to compounds for selectively inhibiting human corticosteroid syntheses CYP11B1 and CYP11B2, to the production thereof and to their use for treating hypercortisolism and diabetes mellitus or insufficiency of the heart and myocardial fibrosis.
本发明涉及用于选择性抑制人类皮质类固醇合成CYP11B1和CYP11B2的化合物,其制备方法以及它们用于治疗高皮质醇症和糖尿病或心脏功能不全和心肌纤维化的应用。